These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 8549868)

  • 1. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients.
    Velussi M; Brocco E; Frigato F; Zolli M; Muollo B; Maioli M; Carraro A; Tonolo G; Fresu P; Cernigoi AM; Fioretto P; Nosadini R
    Diabetes; 1996 Feb; 45(2):216-22. PubMed ID: 8549868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function in noninsulin-dependent diabetes mellitus patients treated with angiotensin-converting enzyme inhibitors and calcium channel blockers.
    Nosadini R; Brocco E; Saller A; Cernigoi AM; Abaterusso C; Bortoloso E; Dalla Vestra M; Maioli M; Piarulli F; Fioretto P
    J Hypertens Suppl; 1998 Sep; 16(4):S27-32. PubMed ID: 9817189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
    Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG;
    JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year prospective study of glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients.
    Silveiro SP; Friedman R; de Azevedo MJ; Canani LH; Gross JL
    Diabetes Care; 1996 Feb; 19(2):171-4. PubMed ID: 8718441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
    Waeber B; Weidmann P; Wohler D; Le Bloch Y
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
    Agodoa LY; Appel L; Bakris GL; Beck G; Bourgoignie J; Briggs JP; Charleston J; Cheek D; Cleveland W; Douglas JG; Douglas M; Dowie D; Faulkner M; Gabriel A; Gassman J; Greene T; Hall Y; Hebert L; Hiremath L; Jamerson K; Johnson CJ; Kopple J; Kusek J; Lash J; Lea J; Lewis JB; Lipkowitz M; Massry S; Middleton J; Miller ER; Norris K; O'Connor D; Ojo A; Phillips RA; Pogue V; Rahman M; Randall OS; Rostand S; Schulman G; Smith W; Thornley-Brown D; Tisher CC; Toto RD; Wright JT; Xu S;
    JAMA; 2001 Jun; 285(21):2719-28. PubMed ID: 11386927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
    Nosadini R; Velussi M; Brocco E; Bruseghin M; Abaterusso C; Saller A; Dalla Vestra M; Carraro A; Bortoloso E; Sambataro M; Barzon I; Frigato F; Muollo B; Chiesura-Corona M; Pacini G; Baggio B; Piarulli F; Sfriso A; Fioretto P
    Diabetes; 2000 Mar; 49(3):476-84. PubMed ID: 10868971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
    Diabetes; 2001 Apr; 50(4):843-50. PubMed ID: 11289051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
    Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amlodipine and cilazapril treatment on platelet Ca2+ handling in spontaneously hypertensive rats.
    Oshima T; Ono N; Ozono R; Higashi Y; Ishida M; Ishida T; Miho N; Nakashima H; Yano Y; Kambe M
    Hypertens Res; 2003 Nov; 26(11):901-6. PubMed ID: 14714582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
    Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiotensin-converting enzyme inhibition versus conventional antihypertensive therapy on the glomerular filtration rate.
    Hansson L
    Cardiology; 1995; 86 Suppl 1():30-3. PubMed ID: 7614504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combination therapy of angiotensin-converting enzyme inhibitor plus calcium channel blocker on urinary albumin excretion in hypertensive microalbuminuric patients with type II diabetes.
    Shigihara T; Sato A; Hayashi K; Saruta T
    Hypertens Res; 2000 May; 23(3):219-26. PubMed ID: 10821130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporine-treated renal allograft recipients.
    Sennesael JJ; Lamote JG; Violet I; Tasse S; Verbeelen DL
    Am J Kidney Dis; 1996 May; 27(5):701-8. PubMed ID: 8629631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension.
    Himmelmann A; Hansson L; Hansson BG; Hedstrand H; Skogström K; Ohrvik J; Furängen A
    Blood Press; 1995 Mar; 4(2):85-90. PubMed ID: 7599759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.
    Tatti P; Pahor M; Byington RP; Di Mauro P; Guarisco R; Strollo G; Strollo F
    Diabetes Care; 1998 Apr; 21(4):597-603. PubMed ID: 9571349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.